NVS

Recent Articles

6 More Pharma Companies Selling Overpriced Drugs

Overpriced drugs are more common with the pharma industry than most realize, and these names are the worst offenders. More 

Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)

Merck is a blue-chip dividend stock that may be a solid investment, however MRK's dividend growth lags other competitors More 

3 Pharmaceuticals Stocks to Sell Now

This week, 3 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

11 Pharmaceuticals Stocks to Sell Now

This week, the ratings of 11 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

4 Stocks to Save You From the Next Market Crash

Is the next market brushfire right around the corner? Here are 4 stocks to add to your portfolio that can shield you from danger More 

10 Pharmaceuticals Stocks to Sell Now

The ratings of 10 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Broker Darlings of the Dow: Pfizer Inc. (PFE)

A study of recommendations at the major brokerages shows Pfizer is the #7 broker pick, out of the 30 stocks in the Dow More